Thus, the combination of previous and current research results further revealed that CCR2, CXCR2, S100A9, PTPRC, S100A8, S100A12 might be involved in inflammatory and immune processes that eventually result in NAFLD and AF. The gene discussed is S100A9; the disease is metabolic dysfunction-associated steatotic liver disease.